Predictive Medicine Depends on Analytics
Harvard Business Review
OCTOBER 23, 2014
That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.
8 
Let's personalize your content